306 Publications (Page 6 of 13)
2010
Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease.Cummings, Jeffrey L⋅Farlow, Martin R⋅Meng, Xiangyi⋅Tekin, Sibel and Olin, Jason TClinical drug investigation, vol. 30, (no. 1), pp. 41-9, 2010.
| Journal Article
Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid [beta] After a Single Administration of an Amyloid [beta] Monoclonal Antibody in Subjects With Alzheimer DiseaseSiemers, Eric R⋅Friedrich, S.⋅Dean, RA⋅Gonzales, CR⋅Farlow, Martin R⋅Paul, Steven M and DeMattos, RBClinical Neuropharmacology, vol. 33, (no. 2), pp. 67-73, 2010.
| Journal Article
Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?Farlow, Martin RAlzheimer's research & therapy, vol. 2, (no. 3), pp. 15, 2010.
| Journal Article
The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease.Farlow, Martin R⋅Grossberg, George⋅Gauthier, Serge⋅Meng, Xiangyi and Olin, Jason TCurrent medical research and opinion, vol. 26, (no. 10), pp. 2441-7, 2010/Oct.
| Journal Article
Validation of Consensus Panel Diagnosis in DementiaMJ, Gabel⋅Gabel, Matthew J⋅Gabel, Matthew J⋅Foster, Norman L⋅Foster, Norman L⋅NL, Foster⋅JL, Heidebrink⋅Heidebrink, Judith L⋅Heidebrink, Judith L⋅Higdon, Roger⋅R, Higdon⋅Higdon, Roger⋅HJ, Aizenstein⋅Aizenstein, Howard J⋅Aizenstein, Howard J⋅Arnold, Steven E⋅SE, Arnold⋅Arnold, Steven E⋅Barbas, Nancy R⋅NR, Barbas⋅Barbas, Nancy R⋅BF, Boeve⋅Boeve, Bradley F⋅Boeve, Bradley F⋅JR, Burke⋅Burke, James R⋅Burke, James R⋅Clark, Christopher M⋅CM, Clark⋅Clark, Christopher M⋅ST, Dekosky⋅Dekosky, Steven T⋅DeKosky, Steven T⋅Farlow, Martin R⋅Farlow, Martin R⋅MR, Farlow⋅WJ, Jagust⋅Jagust, William J⋅Jagust, William J⋅Kawas, Claudia H⋅EY, Zamrini⋅Kawas, Claudia H⋅Koeppe, Robert A⋅Koeppe, Robert A⋅Leverenz, James B⋅Leverenz, James B⋅Lipton, Anne M⋅Lipton, Anne M⋅Peskind, Elaine R⋅Peskind, Elaine R⋅Turner, Raymond S⋅Turner, R. Scott⋅Womack, Kyle B⋅Womack, Kyle⋅Zamrini, Edward Y and Zamrini, Edward YArchives of Neurology, vol. 67, (no. 12), Dec 2010.
| Journal Article
2009
Adipose stromal cells-secreted neuroprotective media against neuronal apoptosisWei, X.⋅Zhao, L.⋅Zhong, J.⋅Gu, H.⋅Feng, D.⋅Johnstone, Brian⋅March, Keith L⋅Farlow, Martin R and Du, YanshengNeuroscience Letters, vol. 462, (no. 1), pp. 76-79, 2009.
| Journal Article
Correlation of clinical features with argyrophilic grains at autopsy.Sabbagh, Marwan N⋅Sandhu, Sonny S⋅Farlow, Martin R⋅Vedders, Linda⋅Shill, Holly A⋅Caviness, John N⋅Connor, Donald J⋅Sue, Lucia⋅Adler, Charles H and Beach, Thomas GAlzheimer disease and associated disorders, vol. 23, (no. 3), pp. 229-33, 2009 Jul-Sep.
| Journal Article
Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophyLandsverk, Megan L⋅Ruzzo, Elizabeth K⋅Mefford, Heather⋅Buysse, Karen⋅Buchan, Jillian G⋅Eichler, Evan E⋅Petty, Elizabeth M⋅Peterson, Esther A⋅Knutzen, Dana M⋅Barnett, Karen⋅Farlow, Martin R⋅Caress, Judy⋅Parry, Gareth J⋅Quan, Dianna⋅Gardner, Kathy L⋅Hong, Ming⋅Simmons, Zachary⋅Bird, Thomas D⋅Chance, Phillip F and Hannibal, Mark CHuman Molecular Genetics, vol. 18, (no. 7), pp. 1200-1208, 2009.
| Journal Article
IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats.Wei, Xing⋅Wei, Xing⋅Du, Zhimei⋅Du, Zhimei⋅Zhao, Liming⋅Zhao, Liming⋅Feng, Dongni⋅Feng, Dongni⋅Wei, Gang⋅Wei, Gang⋅He, Yongzheng⋅He, Yongzheng⋅Tan, Jiangning⋅Tan, Jiangning⋅Lee, Wei-Hui⋅Lee, Wei‐Hui⋅Hampel, Harald⋅Hampel, Harald⋅Dodel, Richard⋅Dodel, Richard⋅Johnstone, Brian H⋅Johnstone, Brian⋅March, Keith L⋅March, Keith L⋅Farlow, Martin R⋅Farlow, Martin R⋅Du, Yansheng and Du, YanshengStem cells (Dayton, Ohio), vol. 27, (no. 2), pp. 478-88, 2009/Feb.
| Journal Article
The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's diseaseFarlow, MartinLancet Neurology, The, vol. 8, (no. 1), pp. 23, 2009.
| Journal Article
Treatment of Mild Cognitive Impairment (MCI)Farlow, Martin RCurrent Alzheimer Research, vol. 6, (no. 4), pp. 362-367, 2009.
| Journal Article
2008
A Modern Hypothesis: The Distinct Pathologies of Dementia Associated with Parkinson's Disease versus Alzheimer's DiseaseFarlow, Martin R and Cummings, Jeffrey LDementia and Geriatric Cognitive Disorders, vol. 25, (no. 4), pp. 301-308, 2008.
| Journal Article
Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-induced neurotoxicity.Wei, X⋅Ma, Z⋅Fontanilla, C V⋅Zhao, L⋅Xu, Zao C⋅Taggliabraci, V⋅Johnstone, Brian⋅Dodel, R C⋅Farlow, Martin R and Du, YanshengNeuroscience, vol. 155, (no. 4), pp. 1098-105, 2008/Sep/9.
| Journal Article
In vivo and postmortem clinicoanatomical correlations in frontotemporal dementia and parkinsonism linked to chromosome 17.Ghetti, Bernardino⋅Ghetti, Bernardino⋅Spina, Salvatore⋅Spina, Salvatore⋅Murrell, Jill R⋅Murrell, Jill R⋅Huey, Edward D⋅Huey, Edward D⋅Pietrini, Pietro⋅Pietrini, Pietro⋅Sweeney, Brian⋅Sweeney, Brian⋅Wassermann, Eric M⋅Wassermann, Eric M⋅Keohane, Catherine⋅Keohane, Catherine⋅Farlow, Martin R⋅Farlow, Martin R⋅Grafman, Jordan H and Grafman, JordanNeuro-degenerative diseases, vol. 5, (no. 3-4), pp. 215-7, 2008.
| Journal Article
Memantine for the Treatment of Alzheimer’s DiseaseFarlow, Martin⋅Graham, Stephen and Alva, GustavoDrug Safety, vol. 31, (no. 7), pp. 585, 20080700.
| Journal Article
Memantine for the Treatment of Alzheimer's Disease: Tolerability and Safety Data from Clinical TrialsFarlow, Martin R⋅Graham, Stephen M and Alva, GustavoDrug Safety, vol. 31, (no. 7), pp. 577-585, 2008.
| Journal Article
Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.Bekris, Lynn⋅Millard, Steven P⋅Galloway, Nichole M⋅Vuletic, Simona⋅Albers, John J⋅Li, Gail⋅Galasko, Douglas R⋅De Carli, Charles D⋅Farlow, Martin R⋅Clark, Christopher M⋅Quinn, Joseph F⋅Kaye, Jeff⋅Schellenberg, Gerard D⋅Tsuang, Debby W⋅Peskind, Elaine R and Yu, Chang EnJournal of Alzheimer's disease : JAD, vol. 13, (no. 3), pp. 255-66, 2008/Apr.
| Journal Article
Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease.Fleisher, Adam S⋅Raman, Rema⋅Siemers, Eric R⋅Becerra, Lida⋅Clark, Christopher M⋅Dean, Robert A⋅Farlow, Martin R⋅Galvin, James E⋅Peskind, Elaine R⋅Quinn, Joseph F⋅Sherzai, Abdullah⋅Sowell, B B⋅Aisen, Paul S and Thal, Leon JArchives of neurology, vol. 65, (no. 8), pp. 1031-8, 2008/Aug.
| Journal Article
Phase 2 Safety Trial Targeting Amyloid B Production With a [gamma]-Secretase Inhibitor in Alzheimer DiseaseFleisher, Adam S⋅Raman, Rema⋅Siemers, Eric R⋅Becerra, Lida⋅Clark, Christopher M⋅Dean, Robert A⋅Farlow, Martin R⋅Galvin, James E⋅Peskind, Elaine R⋅Quinn, Joseph F⋅Sherzai, Abdullah⋅Sowell, B B⋅Aisen, Paul S and Thal, Leon JArchives of Neurology, vol. 65, (no. 8), Aug 2008.
| Journal Article
Randomized Clinical Trial Results for Donepezil in Alzheimer's Disease: Is the Treatment Glass Half Full or Half Empty?Farlow, Martin RJournal of the American Geriatrics Society, vol. 56, (no. 8), pp. 1567, 2008-08-00.
| Journal Article
Synergistic effect of apolipoprotein E 4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimerʼs diseaseLane, Roger⋅Lane, Roger⋅Lane, R.⋅Feldman, H.H.⋅Feldman, Howard⋅Feldman, Howard⋅Meyer, Joanne⋅Meyer, Joanne⋅Meyer, J.⋅He, Yunsheng⋅He, Y.⋅He, Yunsheng⋅Ferris, Steven⋅Ferris, S.H.⋅Ferris, Steven H⋅Nordberg, A.⋅Nordberg, Agneta⋅Nordberg, Agneta⋅Darreh-Shori, Taher⋅Darreh-Shori, Taher⋅Darreh-Shori, T.⋅Soininen, Hilkka⋅Soininen, H.⋅Soininen, Hilkka⋅Pirttilä, Tuula⋅Pirttilä, Tuula⋅Pirttilä, T.⋅Farlow, Martin⋅Farlow, Martin R⋅Farlow, M.R.⋅Sfikas, Nikolaos⋅Sfikas, Nikolaos⋅Sfikas, N.⋅Ballard, Clive⋅Ballard, C.⋅Ballard, Clive⋅Greig, Nigel⋅Greig, N.H. and Greig, Nigel HPharmacogenetics and Genomics, vol. 18, (no. 4), pp. 298, 2008-April.
| Journal Article
The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD familySpina, Salvatore⋅Spina, Salvatore⋅Farlow, Martin R⋅Farlow, Martin R⋅Unverzagt, Frederick W⋅Unverzagt, Frederick⋅Kareken, David A⋅Kareken, David A⋅Murrell, Jill R⋅Murrell, Jill R⋅Fraser, Graham⋅Fraser, Graham⋅Epperson, Francine⋅Epperson, Francine⋅Crowther, R Anthony⋅Crowther, RAnthony⋅Spillantini, Maria G⋅Spillantini, Maria G⋅Goedert, Michel⋅Goedert, Michel⋅Ghetti, Bernardino and Ghetti, BernardinoBrain, vol. 131, (no. 1), pp. 72-89, 2008.
| Journal Article
Treatment options in Alzheimer's disease: maximizing benefit, managing expectations.Farlow, Martin R⋅Miller, Michael L and Pejovic, VojislavDementia and geriatric cognitive disorders, vol. 25, (no. 5), pp. 408-22, 2008.
| Journal Article
2007
ALZHEIMER'S DISEASEFarlow, MartinCONTINUUM: Lifelong Learning in Neurology, vol. 13, (no. 2, Dementia), pp. 68, 2007-April.
| Journal Article
Association of statin use with cognitive decline in elderly African AmericansSzwast, SJ⋅Hendrie, Hugh C⋅Lane, KA⋅Gao, Sujuan⋅Taylor, SE⋅Unverzagt, Frederick⋅Murrell, Jill R⋅Deeg, M.⋅Ogunniyi, A.⋅Farlow, Martin R and Hall, Kirsten SNeurology, vol. 69, (no. 19), pp. 1873-1880, 2007.
| Journal Article
